Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should KnowZacks Investment Research • 01/01/24
Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It?Zacks Investment Research • 12/27/23
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)Zacks Investment Research • 12/08/23
Are You Looking for a Top Momentum Pick? Why Amphastar Pharmaceuticals (AMPH) is a Great ChoiceZacks Investment Research • 12/05/23
Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly DealInvestors Business Daily • 12/04/23
Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 11/29/23
Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare ConferenceAccesswire • 11/20/23
Wall Street Analysts See Amphastar (AMPH) as a Buy: Should You Invest?Zacks Investment Research • 11/13/23
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023Accesswire • 11/08/23
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023Accesswire • 11/01/23
Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 10/31/23
Amphastar Pharmaceuticals (AMPH) Rises As Market Takes a Dip: Key FactsZacks Investment Research • 10/23/23